Peter W. de Leeuw

16.1k total citations · 3 hit papers
245 papers, 11.4k citations indexed

About

Peter W. de Leeuw is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter W. de Leeuw has authored 245 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Cardiology and Cardiovascular Medicine, 49 papers in Endocrinology, Diabetes and Metabolism and 38 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter W. de Leeuw's work include Blood Pressure and Hypertension Studies (94 papers), Hormonal Regulation and Hypertension (45 papers) and Heart Rate Variability and Autonomic Control (31 papers). Peter W. de Leeuw is often cited by papers focused on Blood Pressure and Hypertension Studies (94 papers), Hormonal Regulation and Hypertension (45 papers) and Heart Rate Variability and Autonomic Control (31 papers). Peter W. de Leeuw collaborates with scholars based in Netherlands, United States and Italy. Peter W. de Leeuw's co-authors include Abraham A. Kroon, W. H. Birkenhäger, Robert Fagard, Lutgarde Thijs, Jan A. Staessen, Choudomir Nachev, Christopher J. Bulpitt, Gastone Leonetti, Luís M. Ruilope and José L. Rodicio and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Peter W. de Leeuw

236 papers receiving 10.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension

1997 2.1k citations Jan A. Staessen, Robert Fagard et al. profile →
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)

2000 864 citations Peter W. de Leeuw, Luís M. Ruilope et al. profile →
Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension

2011 411 citations John D. Bisognano, George L. Bakris et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter W. de Leeuw Netherlands	49	7.3k	2.2k	1.5k	1.3k	1.3k	245	11.4k
Ehud Grossman Israel	54	5.2k 0.7×	2.2k 1.0×	1.5k 1.0×	826 0.7×	848 0.7×	400	10.3k
Giuseppe Schillaci Italy	62	11.7k 1.6×	2.3k 1.0×	2.7k 1.8×	1.6k 1.2×	1.2k 1.0×	217	16.4k
Gianpaolo Reboldi Italy	52	8.1k 1.1×	2.3k 1.0×	2.0k 1.3×	752 0.6×	1.1k 0.9×	259	14.3k
Thomas D. Giles United States	40	6.3k 0.9×	2.3k 1.0×	1.6k 1.1×	1.2k 0.9×	1.1k 0.9×	288	10.9k
Daniel Duprez United States	50	5.2k 0.7×	1.3k 0.6×	1.9k 1.3×	1.1k 0.9×	549 0.4×	285	9.8k
Sungha Park South Korea	49	4.0k 0.5×	1.1k 0.5×	1.8k 1.2×	1.2k 1.0×	678 0.5×	451	9.3k
Marc De Buyzere Belgium	54	5.8k 0.8×	915 0.4×	1.8k 1.2×	792 0.6×	644 0.5×	315	10.4k
Anthony M. Dart Australia	69	9.0k 1.2×	1.9k 0.8×	2.7k 1.8×	1.3k 1.0×	958 0.8×	315	15.6k
Timothy M. Morgan United States	56	4.5k 0.6×	1.9k 0.8×	1.6k 1.0×	787 0.6×	750 0.6×	138	11.4k
Craig I Coleman United States	56	4.8k 0.7×	1.3k 0.6×	2.0k 1.3×	888 0.7×	596 0.5×	406	11.2k

Countries citing papers authored by Peter W. de Leeuw

Since Specialization

Citations

This map shows the geographic impact of Peter W. de Leeuw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. de Leeuw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. de Leeuw more than expected).

Fields of papers citing papers by Peter W. de Leeuw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. de Leeuw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. de Leeuw. The network helps show where Peter W. de Leeuw may publish in the future.

Co-authorship network of co-authors of Peter W. de Leeuw

This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. de Leeuw. A scholar is included among the top collaborators of Peter W. de Leeuw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. de Leeuw. Peter W. de Leeuw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Uiterwijk, Renske, Julie Staals, Marjolein Huijts, et al.. (2018). Framingham Stroke Risk Profile is related to cerebral small vessel disease progression and lower cognitive performance in patients with hypertension. Journal of Clinical Hypertension. 20(2). 240–245. 16 indexed citations

Leeuw, Peter W. de, John D. Bisognano, George L. Bakris, et al.. (2017). Sustained Reduction of Blood Pressure With Baroreceptor Activation Therapy. Hypertension. 69(5). 836–843. 83 indexed citations

Rossi, Gian Paolo, Teresa Maria Seccia, Matthias Barton, et al.. (2017). Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I. Journal of Hypertension. 36(3). 451–461. 28 indexed citations

Wachter, Rolf, Marcel Halbach, George L. Bakris, et al.. (2016). An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems. Journal of the American Society of Hypertension. 11(2). 81–91. 16 indexed citations

Deckers, Kay, Martin P.J. van Boxtel, Frans R.J. Verhey, et al.. (2016). Dementia risk in renal dysfunction. Neurology. 88(2). 198–208. 101 indexed citations

Luik, Antinus J., Ulrich Gladziwa, Jeroen P. Kooman, et al.. (2015). Blood Pressure Changes in Relation to Interdialytic Weight Gain1. Contributions to nephrology. 106. 90–93.

Huijts, Marjolein, Annelien Duits, Julie Staals, et al.. (2014). Basal Ganglia Enlarged Perivascular Spaces are Linked to Cognitive Function in Patients with Cerebral Small Vessel Disease. Current Neurovascular Research. 11(2). 136–141. 56 indexed citations

Leeuw, Peter W. de & Abraham A. Kroon. (2013). Clinical end points in baroreflex activation therapy: what do we need to know?. Expert Review of Cardiovascular Therapy. 11(6). 683–688.

Bakker, Paul I. W. de, Jasper Bovenberg, Cornelia M. van Duijn, et al.. (2012). How to kickstart a national biobanking infrastructure – experiences and prospects of BBMRI-NL. Nordic Psychology. 21(2). 143–148.

10.

Rennenberg, Roger, Bernard J. van Varik, Leon J. Schurgers, et al.. (2010). Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood. 115(24). 5121–5123. 104 indexed citations

11.

Scheffers, Ingrid, Abraham A. Kroon, Jürg Schmidli, et al.. (2010). Novel Baroreflex Activation Therapy in Resistant Hypertension. Journal of the American College of Cardiology. 56(15). 1254–1258. 244 indexed citations

12.

Wustmann, Kerstin, Jan Kučera, Ingrid Scheffers, et al.. (2009). Effects of Chronic Baroreceptor Stimulation on the Autonomic Cardiovascular Regulation in Patients With Drug-Resistant Arterial Hypertension. Hypertension. 54(3). 530–536. 127 indexed citations

13.

Zee, Anke H. Maitland‐van der, Anthonius de Boer, Abraham A. Kroon, et al.. (2008). Interaction between the Gly460Trp α-adducin gene variant and diuretics on the risk of myocardial infarction. Journal of Hypertension. 27(1). 61–68. 15 indexed citations

14.

Smerecnik, Chris, Ilse Mesters, Hilde van Keulen, et al.. (2007). Should Individuals Be Informed about Their Salt Sensitivity Status? First Indications of the Value of Testing for Genetic Predisposition to Low-Risk Conditions. Genetic Testing. 11(3). 307–314. 7 indexed citations

15.

Staessen, Jan A., Lutgarde Thijs, Robert Fagard, et al.. (2004). Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. Journal of Hypertension. 22(4). 847–857. 147 indexed citations

16.

Pluimers, Frits, Peter W. de Leeuw, J Smak, A.R.W. Elbers, & Arjan Stegeman. (1999). Classical swine fever in The Netherlands 1997–1998: a description of organisation and measures to eradicate the disease. Preventive Veterinary Medicine. 42(3-4). 139–155. 58 indexed citations

17.

Froon, A.H.M., Marc J. M. Bonten, Sandrine Gaillard, et al.. (1998). Prediction of Clinical Severity and Outcome of Ventilator-associated Pneumonia: Comparison of Simplified Acute Physiology Score with Systemic Inflammatory Mediators. American Journal of Respiratory and Critical Care Medicine. 158(4). 1026–1031. 50 indexed citations

18.

Bonten, Marc J. M., A.H.M. Froon, Sandrine Gaillard, et al.. (1997). The Systemic Inflammatory Response in the Development of Ventilator-Associated Pneumonia. American Journal of Respiratory and Critical Care Medicine. 156(4). 1105–1113. 80 indexed citations

19.

Houben, Alphons J.H.M., Nicolaas C. Schaper, Claude Haan, et al.. (1996). Local 24-h hyperglycemia does not affect endothelium-dependent or -independent vasoreactivity in humans. American Journal of Physiology-Heart and Circulatory Physiology. 270(6). H2014–H2020. 46 indexed citations

20.

Leeuw, Peter W. de & W. H. Birkenhäger. (1980). Hypothermia: a possible side effect of prazosin.. BMJ. 281(6249). 1181–1181. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact